CCM
EXAS

Consonance Capital Management’s Exact Sciences EXAS Stock Holding History

Consonance Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-579,666
Closed -$53.6M – 33
2019
Q4 		$53.6M Buy
+579,666
New +$51M 3.27% 12

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Consonance Capital Management's EXAS Position: Q1 2020 in Review

Consonance Capital Management sold out of Exact Sciences (EXAS) in Q1 2020, closing a stake of 579,666 shares — an estimated $53.6M sold.

Consonance Capital Management first reported a position in EXAS in Q4 2019 and held it in 1 quarter. The position peaked at $53.6M in Q4 2019. 476 funds tracked by Wall St. Rank hold EXAS as of Q1 2020.

  • Consonance Capital Management reported no remaining Exact Sciences position as of Q1 2020 after selling out during the quarter.
  • Consonance Capital Management sold 579,666 Exact Sciences shares in Q1 2020, an estimated $53.6M.
  • Consonance Capital Management first reported a position in Exact Sciences in Q4 2019 and held it in 1 quarter.
  • Consonance Capital Management's Exact Sciences position peaked at $53.6M in Q4 2019.
  • 476 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2020.

Based on Consonance Capital Management's 13F filing for Q1 2020, filed 15 May 2020.